Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results

NEWS RELEASE – INSIDE AND REGULATED INFORMATION August 2, 2022, 4:00PM EDT / 22:00 CET Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results Solidifies leadership in the precision diagnostics urology market Provides the most comprehensive menu of advanced molecular tests for urology in prostate cancer Enhances scale […]

MDxHealth Reports Q1-2022 Results

   NEWS RELEASE – REGULATED INFORMATION27 APRIL 2022, 4:00PM EDT / 22:00 CET          MDxHealth Reports Q1-2022 Results